Live Breaking News & Updates on Capricor Company Contact|Page 4

Stay updated with breaking news from Capricor company contact. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Capricor Therapeutics (CAPR) Announces 4.94M Share Offering at $4.66/sh

Capricor Therapeutics (CAPR) Announces 4.94M Share Offering at $4.66/sh
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , New York , Ns Pharma Inc , Exchange Commission , Capricor Company Contact , Capricor Therapeutics Inc , Raquel Conakcsa Strategic Communications , Exchange Commission On , Highbridge Capital Management , Cantor Fitzgerald Co , Nippon Shinyaku Co Ltd , Hc Wainwright Co , Joyce Allairelifesci Advisors , Co Ltd , Capricor Therapeutics , Nippon Shinyaku , Cantor Fitzgerald , Capital Markets , Securities Litigation Reform Act , Annual Report , Quarterly Report , Investigational New Drug , Media Contact , Investor Contact , Company Contact , Chief Financial Officer ,

Capricor Therapeutics Announces $23 Million Registered Direct Offering

SAN DIEGO, Sept. 29, 2023 Capricor Therapeutics , a biotechnology company focused on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of. ....

New York , United States , Joyce Allaire , Raquel Cona , Capricor Therapeutics Inc , Lifesci Advisors , Capricor Company Contact , Exchange Commission , Ns Pharma Inc , Co Ltd , Hc Wainwright Co , Globenewswire Inc , Nippon Shinyaku Co Ltd , Strategic Communications , Highbridge Capital Management , Cantor Fitzgerald Co , Nippon Shinyaku , Capital Management , Capital Markets , Securities Litigation Reform Act , Annual Report , Quarterly Report , Investigational New Drug , Media Contact , Investor Contact , Sci Advisors ,

Capricor Therapeutics Announces $23 Million Registered

SAN DIEGO, Sept. 29, 2023 (GLOBE NEWSWIRE) Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company focused on the development of transformative. ....

New York , United States , Raquel Cona , Joyce Allaire , Nippon Shinyaku Co Ltd , Highbridge Capital Management , Cantor Fitzgerald Co , Strategic Communications , Co Ltd , Hc Wainwright Co , Exchange Commission , Capricor Company Contact , Ns Pharma Inc , Lifesci Advisors , Capricor Therapeutics Inc , Exchange Commission On , Nippon Shinyaku , Cantor Fitzgerald , Capital Markets , Securities Litigation Reform Act , Annual Report , Quarterly Report , Investigational New Drug , Media Contact , Investor Contact , Sci Advisors ,

Capricor Therapeutics Appoints Michael Kelliher to Board of Directors

Capricor Therapeutics Appoints Michael Kelliher to Board of Directors
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

United States , Linda Marb , Raquel Cona , Michael Kelliher , Joyce Allaire , Group Vice , Business Development , Nippon Shinyaku Co Ltd , Exchange Commission On , Perrigo Company , Business Development At Horizon Therapeutics , Elan Corporation , Lifesci Advisors , Strategic Communications , University College Cork Ireland , Ns Pharma Inc , Capricor Therapeutics Inc , Capricor Company Contact , Capricor Therapeutics , Group Vice President , Horizon Therapeutics , Chief Executive , University College Cork , Associated Chartered , Private Securities Litigation Reform Act , Annual Report ,

Capricor Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update

-Presented Statistically Significant 24-Month HOPE-2 Open Label Extension Data at the PPMD Annual Conference- -Enrollment Continues to Progress in HOPE-3, the Phase 3 Trial of CAP-1002 in Duchenne. ....

San Diego , United States , Linda Marb , Joyce Allaire , Yushi Feng , Paul Auwaerter , Philipj Gotwals , Raquel Cona , Business Development , Ns Pharma Inc , Gilead Company , Nippon Shinyaku Co Ltd , Division Of Infectious Diseases , Capricor Company Contact , Globenewswire Inc , Ken Fisher Center , Exosome Platform Technology , Drug Administration , Lifesci Advisors , Novartis Institutes For Biomedical Research , Capricor Therapeutics Inc , Program Management , Duchenne Muscular Dystrophy Program , Johns Hopkins University School Of Medicine , Regulatory Affairs , Strategic Communications ,